paclitaxel has been researched along with Menopause in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabello, C; Oliveira Botelho Ramalho, S; Resende, U; Zeferino, LC | 1 |
| Groshen, S; Lee, AS; Lee, E; Nichols, P; Spicer, D | 1 |
| Chen, D; Ding, LJ; Ren, XC; Teng, XD; Xia, AL; Xia, HP; Xu, ST; Xue, DB; Zhang, SJ | 1 |
| Baima Poma, C; Ferrero, A; Martra, F; Modaffari, P; Perotto, S; Piovano, E; Pivetta, E; Tripodi, E; Zanfagnin, V; Zola, P | 1 |
| Gnant, MF; Jakesz, R; Locker, GJ; Oberhuber, G; Pluschnig, U; Rudas, M; Steger, GG; Taucher, S; Wenzel, C; Zielinski, CC | 1 |
| Antón, A; Cuevas, JM; Estévez, LG; Florián, J; Fortes, J; Herrero, A; Lobo, F; López-Vega, JM; Velasco, A | 1 |
| Abi-Raad, R; Ancukiewicz, M; Assaad, SI; Attia, K; Boucher, Y; Casty, A; Kuter, I; Molokhia, P; Powell, SN; Sullivan, T; Taghian, AG; Yeh, E | 1 |
| Dodd, M; Dowling, G; Jansen, C; Kramer, J; Miaskowski, C | 1 |
| Barnadas, A; Casado, A; Colomer, R; Cortés-Funes, H; Lloveras, B; Lluch, A; Massutí, B; Montero, S; Ojeda, B | 1 |
| Gnant, MF; Jakesz, R; Locker, GJ; Rudas, M; Schmidinger, M; Steger, GG; Taucher, S; Wenzel, C | 1 |
1 review(s) available for paclitaxel and Menopause
| Article | Year |
|---|---|
Potential mechanisms for chemotherapy-induced impairments in cognitive function.
Topics: Anemia; Animals; Antineoplastic Agents; Attention; Blood-Brain Barrier; Cognition Disorders; Cyclophosphamide; Doxorubicin; Encephalitis; Fluorouracil; Humans; Inflammation; Language; Learning; Memory; Menopause; Methotrexate; Neoplasms; Oncology Nursing; Paclitaxel; Psychomotor Performance; Spatial Behavior | 2005 |
5 trial(s) available for paclitaxel and Menopause
| Article | Year |
|---|---|
Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Female; Fever; Humans; Lymphopenia; Menopause; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Palliative Care; Prospective Studies; Safety; Taxoids; Treatment Outcome | 2002 |
Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Menopause; Middle Aged; Neoplasm Staging; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Spain; Taxoids; Treatment Outcome | 2003 |
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Drug Administration Schedule; Extracellular Fluid; Female; Humans; Menopause; Middle Aged; Oxygen Consumption; Paclitaxel | 2005 |
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Female; Humans; Immunohistochemistry; Menopause; Mucin-1; Multivariate Analysis; Paclitaxel; Prospective Studies; Protein Structure, Tertiary; Receptor, ErbB-2; Time Factors; Treatment Outcome | 2000 |
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Menopause; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Palliative Care; Prospective Studies; Survival Rate; Taxoids | 2002 |
4 other study(ies) available for paclitaxel and Menopause
| Article | Year |
|---|---|
Predictors of Pathological Complete Response in Women with Clinical Complete Response to Neoadjuvant Chemotherapy in Breast Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Menopause; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Retrospective Studies | 2018 |
GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Taxoids; Treatment Outcome | 2011 |
[Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Survival Rate; Uterine Neoplasms | 2010 |
A search for predictive factors for hypersensitivity reactions to paclitaxel and platinum salts in chemotherapy for gynecologic pelvic neoplasms.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Menopause; Middle Aged; Multivariate Analysis; Paclitaxel; Pelvic Neoplasms; Platinum Compounds; Retrospective Studies; Risk Factors | 2012 |